How We Chose the TIME100 Most Influential People in Health of 2026

The past year has been a busy one for the global health sector. Innovation shot forward when Dr. Kiran Munsunuru and Dr. Rebecca Ahrens-Nicklas administered the first-ever customized CRISPR therapy to treat a baby’s genetic disease. In promising trials, new immunotherapies cured cancers, and the search for cancer vaccines advanced. Novo Nordisk, led by CEO Mike Doustdar, released the first GLP-1 pill to the market. And, after the Trump Administration cut funding for international aid and medical research...